A promising two-punch therapy for Langerhans cell histiocytosis 06/29/2021 min. read Copied to clipboard Topics cancer Histiocytosis Read Full media story at blogs.bcm.edu Related Stories News Release Oct 09, 2026 New genetic candidates help explain why autism affects males more often than females Health Briefs Oct 08, 2026 HCP Live with Dr. Jacquelyn Powers: Why "Normal" Ferritin Can Miss Iron Deficiency hcplive.com Media Story Oct 08, 2026 BDO Healthcare Game Changer Webcast with Ashok Kurian: AI Build or Buy? Health Tech Strategic Dec... https://engage.bdo.com/wcc/eh/4850573/lp/5185208/ai-build-or-buy-health-tech-strategic-decision-making-for-healthcare-leaders?utm_source=website&utm_medium=BDOSite&utm_campaign=ReputationBuilding&utm_term=HC&utm_content=Healthcare Research Oct 07, 2026 How two cellular pathways team up to drive kidney cysts and tumors Research Oct 07, 2026 ScienceAlert with Dr. David Steffin: A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses... sciencealert.com News Release Oct 06, 2026 Texas Children’s Dr. Michael Taylor Honored by CPRIT for Advancing Childhood Brain Tumor Research See more results 82816 A promising two-punch therapy for Langerhans cell histiocytosis Article